Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Maraviroc as an Immunomodulatory Drug for Antiretroviral-treated HIV Infected Patients Exhibiting Immunologic Failure

NCT00735072 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT00735072
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00735072 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Maraviroc as an Immunomodulatory Drug for Antiretroviral-treated HIV Infected Patients Exhibiting Immunologic Failure
Lead sponsor
University of California, San Francisco
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2008
Completion date
July 31, 2010
Enrollment
45 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infection